Anaptysbio (ANAB) Cash from Investing Activities (QoQ) (2016 - 2026)
Anaptysbio (ANAB) Cash from Investing Activities (QoQ) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Anaptysbio | 1.55 Bn | 1.27 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -52.40% |
| Dec 31, 2025 | -28.84% |
| Sep 30, 2025 | 183.72% |
| Jun 30, 2025 | 145.19% |
| Mar 31, 2025 | 150.51% |
| Dec 31, 2024 | -150.15% |
| Sep 30, 2024 | 2,500.49% |
| Jun 30, 2024 | -103.56% |
| Mar 31, 2024 | 39.53% |
| Dec 31, 2023 | 60.53% |
| Sep 30, 2023 | 249.77% |
| Jun 30, 2023 | -123.95% |
| Mar 31, 2023 | 297.25% |
| Dec 31, 2022 | 166.28% |
| Sep 30, 2022 | 54.32% |
| Jun 30, 2022 | 77.31% |
| Mar 31, 2022 | -369.18% |
| Dec 31, 2021 | -715.32% |
| Sep 30, 2021 | -71.45% |
| Jun 30, 2021 | -33.08% |